Volume 5, Issue 5 p. 730-738
Full Paper

A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety

Matthew B. Boxer Dr.

Matthew B. Boxer Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
Amy M. Quinn Dr.

Amy M. Quinn Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
Min Shen Dr.

Min Shen Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
Ajit Jadhav Dr.

Ajit Jadhav Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
William Leister Dr.

William Leister Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
Anton Simeonov Dr.

Anton Simeonov Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
Douglas S. Auld Dr.

Douglas S. Auld Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
Craig J. Thomas Dr.

Craig J. Thomas Dr.

National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, Maryland 20850 (USA), Fax: (+1) 301-217-5736

Search for more papers by this author
First published: 27 April 2010
Citations: 56

Graphical Abstract

Caspase the friendly target! The role of a nitrile electrophile as a mediator of the covalent interaction between an optimized caspase 1 inhibitor scaffold [NCGC00183434 (4)] is examined. Synthesis, SAR, hydrolytic stability, selected ADME properties and docking models are reported.

Abstract

Herein, we examine the potential of a nitrile-containing propionic acid moiety as an electrophile for covalent attack by the active-site cysteine residue of caspase 1. The syntheses of several cyanopropanate-containing small molecules based on the optimized peptidic scaffold of prodrug VX-765 were accomplished. These compounds were found to be potent inhibitors of caspase 1 (IC50 values ≤1 nM). Examination of these novel small molecules against a caspase panel demonstrated an impressive degree of selectivity for caspase 1 inhibition over other caspase isozymes. Assessment of hydrolytic stability and selected ADME properties highlighted these agents as potentially useful tools for studying caspase 1 down-regulation in various settings, including in vivo analyses.